Carol Robinson

Dame Carol Robinson
Born	Carol Vivien Bradley (1956-04-10) April 10, 1956 Kent, England
Occupation(s)	Chemist, academic
Known for	Mass spectrometry, gas-phase structural biology, protein folding research
Notable work	Founding director of Kavli Institute for Nanoscience Discovery at Oxford; first female professor in chemistry at Cambridge and Oxford; co-founder of OMass Therapeutics

Dame Carol Vivien Robinson (born 10 April 1956) is a distinguished British chemist and served as president of the Royal Society of Chemistry from 2018 to 2020. She has held the prestigious position of Royal Society Research Professor and currently occupies the Dr Lee's Chair of Physical and Theoretical Chemistry at the University of Oxford. Additionally, she is a professorial fellow at Exeter College. Robinson established the Kavli Institute for Nanoscience Discovery at Oxford as its founding director. Prior to her tenure at Oxford, she was a professor specializing in mass spectrometry within the chemistry department at the University of Cambridge.

Early life and education

Carol Vivien Bradley was born in Kent to parents Denis E. Bradley and Lillian (née Holder). Leaving school at age 16, she began her professional journey as a laboratory technician at Pfizer in Sandwich, Kent, where she gained experience with mass spectrometry. Recognized for her aptitude, she pursued further education through evening courses and day-release programs. After obtaining her undergraduate degree, she departed Pfizer to undertake a Master of Science at the University of Swansea, followed by a Ph.D. completed within two years at the University of Cambridge. During her doctoral studies, she was affiliated with Churchill College, Cambridge.

Career and research

After completing a postdoctoral fellowship at the University of Bristol, Robinson joined Oxford’s mass spectrometry unit to investigate protein folding mechanisms. Together with collaborators, she successfully captured protein folding involving the chaperone GroEL, providing evidence that elements of protein secondary structure can be examined in the gas phase.

Robinson broke new ground as the first woman appointed professor in the chemistry departments at both Cambridge (2001) and Oxford (2009). Her pioneering research demonstrated that electrospray ionization mass spectrometry enables detailed analysis of proteins and large macromolecular assemblies in their gaseous states. Beyond studying protein folding, her investigations have encompassed ribosomes, molecular chaperones, and membrane proteins. Her innovations in gas-phase structural biology have significantly enhanced insight into native protein complexes, thereby facilitating drug discovery initiatives.

She also co-founded OMass Therapeutics, an Oxford-based spin-out company that applies mass spectrometry technologies to pharmaceutical development.

Honours and awards

In 2003, Robinson was honored with the Biemann Medal from the American Society for Mass Spectrometry, followed by the Christian B. Anfinsen Award in 2008. She was elected Fellow of the Royal Society (FRS) in 2004 and received the Rosalind Franklin Award that same year. Her nomination by the Royal Society emphasized her groundbreaking use of mass spectrometry to investigate large protein complexes such as GroEL, ribosomes, and virus capsids, showcasing its effectiveness for studying macromolecular assembly and structural conformation.

The Davy Medal was bestowed upon her in 2010 for innovative applications of mass spectrometry to characterize substantial protein complexes. In recognition of her development of gas-phase structural biology through advanced mass spectrometry techniques, she received the Royal Society of Chemistry’s Interdisciplinary Prize in 2011. That year also saw her awarded both the Aston Medal and the FEBS/EMBO Women in Science Award.

Robinson was appointed Dame Commander of the Order of the British Empire (DBE) in 2013 for her contributions to science and industry. Subsequent accolades include the Thomson Medal Award in 2014 and the L'Oréal-UNESCO For Women in Science Award in 2015 for her pioneering work on macromolecular mass spectrometry.

In 2017, she was elected as a Foreign Associate to the US National Academy of Sciences. Later recognitions encompass the American Chemical Society’s Frank H. Field and Joe L. Franklin Award (2018), the Novozymes Prize for founding a new branch within mass spectrometry proteomics (2019), and the Royal Medal.

Her achievements were further acknowledged with the Othmer Gold Medal in 2020; in 2021, she received both the Louis-Jeantet Prize for Medicine and the European Chemistry Gold Medal awarded by the European Chemical Society. That year also marked her induction as an International Honorary Member of the American Academy of Arts and Sciences.

In 2022, Robinson was honored with the Franklin Institute Award for Chemistry. The following year included election to the American Philosophical Society along with receipt of the John B. Fenn Award for Distinguished Contribution to Mass Spectrometry; additionally, she was recognized among the top ten "Innovators and Trailblazers" on The Analytical Scientist’s Power List.

In 2024, Robinson earned the EPO European Inventor Lifetime Achievement Award for advancing biochemical research and medical diagnostics via mass spectrometry. In June of that year, she was awarded an honorary doctorate by the University of Cambridge and inducted into the National Academy of Inventors.

She has been granted thirteen honorary doctorates from institutions such as Weizmann Institute of Science, Aarhus University Denmark, University of Kent, University of York, and University of Bristol.

On 10 August 2025, Robinson featured on BBC Radio 4’s Desert Island Discs.

External links

• (refer to Denis Noble)
• (conversation led by Erick M. Carreira)